Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients

Atherosclerosis. 2005 Aug;181(2):403-5. doi: 10.1016/j.atherosclerosis.2005.01.034. Epub 2005 Feb 17.

Abstract

Postprandial hypertriglyceridemia is considered as a risk factor for cardiovascular disease in Type 2 diabetes. However, little is known about the underlying mechanisms. Since the recently discovered apolipoprotein (apo) AV was identified as a modulator of triglyceride (TG) metabolism, the aim of the study was to determine the postprandial apoAV profile of Type 2 diabetic patients. We compared data from 11 patients with Type 2 diabetes mellitus to that of 12 non-diabetic normolipidemic subjects following the ingestion of a lipid-rich cream. Postprandial apoAV was elevated in diabetic patients but no correlation was observed either with plasma TG concentration or with the intensity of lipoprotein lipase-dependent lipolysis. These data obtained in human subjects suggest that plasma apoAV concentration does not play an acute or a direct role in the regulation of plasma TG in the postprandial state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-V
  • Apolipoproteins / blood*
  • Apolipoproteins A
  • Diabetes Mellitus, Type 2 / blood*
  • Humans
  • Hypertriglyceridemia / blood*
  • Lipolysis / physiology
  • Male
  • Middle Aged
  • Postprandial Period / physiology
  • Triglycerides / blood*

Substances

  • APOA5 protein, human
  • Apolipoprotein A-V
  • Apolipoproteins
  • Apolipoproteins A
  • Triglycerides